Taylor Frigon Capital Management’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.15M | Sell |
180,449
-11,211
| -6% | -$134K | 1.15% | 41 |
|
2025
Q1 | $2.28M | Sell |
191,660
-20,586
| -10% | -$245K | 1.36% | 16 |
|
2024
Q4 | $3.26M | Sell |
212,246
-162,551
| -43% | -$2.5M | 1.65% | 17 |
|
2024
Q3 | $4.2M | Sell |
374,797
-49,738
| -12% | -$558K | 2.09% | 5 |
|
2024
Q2 | $2.29M | Buy |
424,535
+438
| +0.1% | +$2.36K | 1.09% | 35 |
|
2024
Q1 | $2.88M | Buy |
424,097
+71,491
| +20% | +$486K | 1.37% | 30 |
|
2023
Q4 | $2.39M | Sell |
352,606
-1,262
| -0.4% | -$8.57K | 1.2% | 32 |
|
2023
Q3 | $1.77M | Buy |
353,868
+107,441
| +44% | +$538K | 0.99% | 41 |
|
2023
Q2 | $1.78M | Buy |
246,427
+78,438
| +47% | +$568K | 0.87% | 46 |
|
2023
Q1 | $1.42M | Sell |
167,989
-3,725
| -2% | -$31.4K | 0.77% | 57 |
|
2022
Q4 | $1.45M | Sell |
171,714
-7,066
| -4% | -$59.8K | 0.83% | 47 |
|
2022
Q3 | $1.85M | Buy |
178,780
+4,054
| +2% | +$42K | 0.97% | 42 |
|
2022
Q2 | $2.28M | Sell |
174,726
-6,603
| -4% | -$86.2K | 1.19% | 33 |
|
2022
Q1 | $1.89M | Buy |
181,329
+6,176
| +4% | +$64.3K | 0.7% | 51 |
|
2021
Q4 | $1.97M | Sell |
175,153
-1,111
| -0.6% | -$12.5K | 0.62% | 51 |
|
2021
Q3 | $3.13M | Buy |
176,264
+574
| +0.3% | +$10.2K | 1.01% | 44 |
|
2021
Q2 | $3.35M | Buy |
175,690
+119,773
| +214% | +$2.29M | 1.05% | 44 |
|
2021
Q1 | $1.18M | Buy |
+55,917
| New | +$1.18M | 0.36% | 69 |
|